| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |